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ABSTRACT 
This study explored the benefits of a hand-held fan as perceived by patients with chronic 
breathlessness and their carers. 
A secondary multimethod analysis was conducted of interview data collected in three 
clinical trials. Two researchers independently coded level of benefit qualitatively reported 
by each patient. Univariate and multivariate statistics were used to explore perceived 
benefit as a factor of gender, age and diagnosis. Qualitative analysis used an integrative 
method.  
One-hundred-and-thirty-three patients commented on the fan, of whom 72 had a carer. 
Diagnoses included non-malignant (n=91, 68.4%) and malignant (n=21, 15.8%) conditions. 
Of 111 patients who provided code-able data, 4(3.6%) perceived no benefit, 16(14.4%) were 
uncertain, 80(72.0%) some benefit, and 11(10.0%) substantial benefit.  Multivariate analysis  
was inconclusive. Benefit was described in terms of shorter recovery time, especially after 
activity. Ten (7.5%) patients said the fan reduced their need for home oxygen or inhaled 
beta-agonist medications. Negative perceptions  of a few included dislike of the cooling 
sensation and embarrassment in public.  
Findings suggest that a hand-held fan is a portable intervention with few disadvantages 
from which  most patients with chronic breathlessness will derive benefit alongside other 
non-pharmacological and pharmacological strategies. Research is needed to optimise 
guidance on fan administration.   
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MANUSCRIPT 
Introduction 
Chronic breathlessness is a common, devastating and hard-to-treat symptom in people with 
advanced illnesses such as chronic obstructive pulmonary disease (COPD) and cancer. It is 
defined as “an unpleasant sensation of breathlessness caused by an underlying disease or 
disease, which persists despite optimum treatment directed at the underlying disease” ([1], 
p.204). Chronic breathlessness has been described as a syndrome whereby breathlessness 
persists despite optimal treatment of the underlying cause, and which leads to disability [2]. 
Chronic breathlessness can have a range of interacting causes [3], as well as complex 
relationships with other symptoms, notably anxiety and fatigue [4]. The experience of 
breathlessness varies between individuals and includes three dimensions: ‘sensory-
perceptual’ (severity and quality), ‘affective’ (unpleasantness and distress) and ‘impact’ 
(effects on everyday life) [5]. The affective domain may in turn consist of different 
dimensions, including breathing discomfort and emotional response [6]. 
While chronic breathlessness cannot be cured, it can be managed with non-pharmacological 
and pharmacological therapies aimed at modulating the perception of breathlessness and 
the person’s response to it [1, 7]. A range of non-pharmacological strategies are available, 
with variable evidence to support their use [8-11]. Among other strategies, a hand-held fan 
(‘fan’) has been recommended for managing acute exacerbations of breathlessness 
(‘breathlessness crises’) by the American Thoracic Society (ATS) [12]. Hypothesised, but only 
partially understood, mechanisms are likely to be multi-factorial and concern stimulation of 
facial temperature receptors [13] and modulation of  central perception of breathlessness 
[14]. Studies evaluating the fan to date have yielded promising results but suggest that 
nuances in the nature of benefit and administration of the fan require further exploration. 
Two randomized controlled trials (RCTs) found a statistically significant reduction in 
breathlessness severity from the fan, both of which focused on short-term administration 
(single use or during one week) [15, 16]. Two further phase II mixed-methods RCTs were not 
designed to test efficacy but yielded qualitative data suggesting that the fan reduced 
recovery time after activity and conferred a feeling of control for some patients [17, 18]. 
Two other qualitative analyses suggest that patient characteristics and nuances in the way 
fans are used may determine the degree and type of benefit experienced [19, 20]. However, 
patient experiences of the fan were not the primary focus of these analyses and thus were 
not evaluated in detail. The current study aimed to provide an in-depth exploration of the 
benefits of the fan vis-à-vis other management strategies as perceived by patients and 
carers. 
Methods 
Sample 
A secondary analysis was conducted of qualitative interview data from three RCTs. The first 
of these (the Breathlessness Intervention Service [BIS] Study) evaluated a comprehensive 
breathlessness management service not limited to the fan alone compared with usual care 
from local services; the second (the Calming Hand and Fan Feasibility [CHAFF] Study) 
evaluated the fan with/without a relaxation intervention (the Calming Hand); and the third 
(the Fan, Activity, Breathlessness [FAB] Study) evaluated the fan at low and high flow rates. 
Both the CHAFF and FAB studies compared intervention arms in addition to simple exercise 
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advice against the advice alone. In all three studies, participants were provided with the 
same verbal and written instruction on how to use the fan by a health professional. 
Participants were told that the fan might reduce breathlessness by means of a draught of 
cool air directed at the face. Patients were instructed to hold the fan 6 inches from their 
face and direct it at their nose or mouth, either keeping it still or moving it around as 
preferred. Patients and carers in the trials’ comparison arms were offered the fan at the end 
of the trial periods. A summary of study characteristics is provided in Table 1. National Health 
Service ethical permission was not required for pooling of anonymised data for secondary analysis 
[21]. Appropriate ethics approval had been obtained for each of the contributing studies. 
Table 1 about here 
 
Data collection 
All patients and carers in the BIS study were offered the opportunity of participating in semi-
structured interview. CHAFF Study participants were purposively sampled for cancer/non-
cancer, carer/no carer, sex, age, socio-economic status and baseline severity of 
breathlessness. FAB Study participants were purposively sampled for cancer/non-cancer, 
carer/no carer and sex. Interviews were conducted at the patients’ or carers’ homes or 
place of care either by members of the clinical team (CHAFF and FAB studies) or an 
independent research team blinded to allocation (BIS Study). All interviews in CHAFF and 
FAB studies included questions on the perceived value of the hand-held fan, whereas those 
in BIS covered all aspects of the service and participant reference to the fan came in 
response to either broad questions (e.g. “What sort of help has the service given you?”) or 
sometimes direct questions about the fan where participants did not refer to it 
spontaneously (see Table 1). Transcribed qualitative data referring to the fan were extracted 
from patient and carer interview transcripts for secondary analysis. 
Analysis 
While all data analysed were qualitative, analysis used a multimethod approach that 
included quantification of patient-perceived benefit from the fan and its relationship to 
patient characteristics as well as qualitative analysis to gain more in-depth insights into 
patient and carer attitudes, beliefs and behaviors. 
Quantitative analysis 
Two independent analysts reviewed qualitative data from each patient and classified his/her 
overall perception of fan-benefit into one of four categories: ‘no perceived benefit’, 
‘uncertain about benefit’, ‘some perceived benefit’ or ‘very substantial perceived benefit’. 
Because patients described perceived benefits in diverse ways, the analysts were instructed 
to classify according to overall impression rather than any standardized criteria. To increase 
reliability, only those patients where both reviewers independently classified in the same 
category were included in the final count. To control for the possibility that BIS patients who 
derived benefit from the fan were more likely to discuss it at interview, a sensitivity analysis 
was conducted in which patients who did not mention the fan were assumed to have 
derived no benefit, and percentages in each category re-calculated. 
To explore relationships between perceived benefit and patient characteristics, chi-square 
analyses were used to compare the proportion of people reporting some/very substantial 
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perceived benefit with no/uncertain benefit on the basis of gender, age (<70/70+ years) and 
diagnosis (non-malignant/malignant). These characteristics have previously been associated 
with variations in breathlessness experience [22, 23]. Variability in sample size prevented 
statistical comparison between BIS, CHAFF and FAB. In view of the exploratory nature of the 
work, we retained patient characteristics associated with perceived benefit at a p<0.25 level 
for inclusion as covariates in a binary logistic regression model to examine multivariate 
relationships [24].  
Qualitative analysis 
Qualitative analysis used an integrative method designed specifically for informing health 
service interventions [25]. Analysis was both deductive (i.e. focused on our research aims) 
and inductive (i.e. open to unexpected insights from participants’ experiences). A coding 
structure was developed to capture variability in: positive or negative appraisals of the fan; 
speculation regarding mechanism of benefit; timing, frequency, duration, positioning and 
location of fan use; fan use in conjunction with, or instead of, other management strategies; 
and ideas for optimizing the fan’s technical specifications. To reduce the risk of bias and 
enrich interpretation, analysis of one-third of interviews was conducted independently by 
two researchers who then met to agree divergences. Other interviews were coded by a 
single researcher and discussed with a second. The coding structure and illustrative data 
were reviewed by the whole research team before being finalised. NVivo version 11 
software was used to manage data and enable codes to be cross-referenced to explore 
relationships.  
Results 
Sample characteristics 
Out of a total of 176 patient interviews, 133 included content on use of the fan: 111/154 
from BIS, 11/11 from CHAFF and 11/11 from FAB. Seventy two patients had a carer who was 
also interviewed, 48 of whom were interviewed with the patient and 24 separately. Not all 
carers interviewed for the BIS Study mentioned the fan. Patients had a mean age of 71 years 
(SD+ 10.7), and 68 (51%) were female. Diagnoses documented as likely to cause 
breathlessness included COPD in 68 (51%) cases, other non-malignant conditions in 23 
(17%), lung cancer or metastases in 21 (16%) and other malignancies in 26 (19%); five 
patients had more than one diagnosis. 
Quantitative analysis 
Two independent reviewers achieved 100% agreement on all 111 patients who provided a 
code-able comment on whether they derived benefit from the fan: 91 from BIS, 11 from 
CHAFF and 9 from FAB. Of these 111, 4 (3.6%) perceived no benefit, 16 (14.4%) were 
uncertain, 80 (72.0%) perceived some benefit, and 11 (10.0%) perceived very substantial 
benefit. The sensitivity analysis (N=154) increased the percentage in the ‘no benefit’ 
category to 30% (n=47), with 10% (n=16) uncertain, 52% (n=80) perceiving some benefit, 
and 7% (n=11) perceiving very substantial benefit. 
Univariate analyses found only age to have a significant relationship (p<0.05) with benefit, 
with patients aged <70 years more likely to perceive benefit than those older (chi-
square=4.270; p=0.039). Diagnosis was entered as a covariate into the regression model 
because patients with a malignant diagnosis were more likely to perceive benefit than those 
with non-malignant at the p<0.25 level (chi square=1.952; p=0.162). The relationship 
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between patient age and perceived benefit became non-significant in the multivariate 
analysis (odds ratio = 0.35 [95% confidence intervals 0.10-1.15]; p=0.084), and the 
relationship of diagnosis to perceived benefit was also further reduced (odds ratio = 0.57 
[95% confidence intervals 0.17-1.93; p=0.365). 
Qualitative analysis 
Perceived benefit from the fan  
Patients were typically classified as perceiving very substantial benefits because they 
reported taking the fan everywhere with them and/or considered it their most valued 
therapeutic strategy for breathlessness. 
“I never go anywhere without it” (BIS 639) 
Benefits to breathlessness were typically described in terms of shortening the time taken to 
recover from breathlessness, especially after physical activity.  
“It seems to recover from the breathlessness quicker than what it does if I don’t use 
the fan. If I am somewhere where I haven’t got the fan and I’ve got breathless, then it 
might be ten/fifteen minutes before I’ve actually recovered, whereas, with the fan, 
it’s usually within five minutes recovery. So it’s, it is quite a bit. Obviously it depends 
how breathless I’ve got but the fan does seem a lot quicker” (FAB 14) 
Most BIS Study participants named the fan as the most useful strategy they had received 
from the service, although a small number of patients with non-malignant disease indicated 
that this was because they had already been familiar with more commonly used strategies 
such as breathing techniques and relaxation. 
“I think that fan was as good as anything, yeah.  I mean I’ve sort of coped with this 
for years now, so I know how to do it really” (BIS 161) 
Some participants made only vague reference to the fan “working” or “helping”, without 
characterising this further. Others referred to “airflow”, “cooling” or “fresh air” either as a 
way of describing the benefit or as a perceived mechanism. 
“Sometimes when I get into bed and I’m squished up, I just have a bit of a fan just to 
cool me down a bit and get the air flowing again” (BIS 523) 
 “The more fresh air and cold air I get, the more I love it, me!” (BIS 77) 
A small number of patients described the mechanism of air flow in terms of air being 
“pushed” or otherwise transiting into the lungs more easily during inhalation. These patients 
all had COPD or lung cancer, but not all patients with these conditions used the same 
description. 
“If I’m breathless and I can’t get my breath and I sit down and I’m really struggling, 
you put it on and actually the air goes in” (BIS 530) 
Perceptions that cooling somehow helped with breathlessness contrasted with reports from 
one patient who used the fan for cooling in a more literal sense but perceived no benefit to 
breathlessness. 
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“I can’t stand it on my nose or my mouth, but when it gets really hot, my ear lobes, 
on the back of my neck, and my forehead, it just cools me right down!” (FAB2) 
Participants also speculated mechanisms relating to distraction, relaxation, and increased 
sense of control and confidence. 
“It takes your mind off of it, so it could be mind over matter, it could be your brain 
saying, you know” (BIS 566) 
 “Sometimes when I’m out and I come over all hot, that’s when I panic breathe. [I] 
used to put the fan on, and - that is - to calm me down” (BIS 538) 
 “It isn’t just the fact that it’s the fan, it’s everything that’s enveloped in the fact that 
I’ve got this fan and it’s … it’s almost like the placebo effect, this fan” (BIS 001) 
The confidence conferred by the fan was sometimes, in turn, associated with an 
improvement in physical functioning and independence. 
 “Because now I’ve got something that I know if I do get breathless. Rather than go 
into a panic, I know I can pick up the fan and it’s going to make me feel better … 
whereas once upon a time I would say ‘if it hasn’t got a lift, I’m not going up the 
stairs’” (BIS 137) 
Many participants who perceived benefits reported being initially skeptical that the fan 
would work.  
 “I thought, well I’ll give it a go like, but I didn’t have a lot of faith in it, do you know 
what I mean? But I would definitely say that was the best thing that I’ve ever done” 
(BIS 106) 
 
Carers did not differ from patients in their perceptions of benefit, although sometimes 
volunteered opinions that the fan had been beneficial even when the patient had been less 
forthcoming. 
“When he gets gasping for breath you use that, don’t you? I mean that’s just a small 
thing but it’s been very helpful”. (Carer, BIS 563) 
Several patients expressed puzzlement that the fan had not been recommended to them 
earlier. 
“Why wasn’t something like that suggested to me while I was in hospital 16 days?” 
(BIS 639) 
Ways of using the fan 
There was substantial variability in the ways that patients used the fan vis-à-vis other 
strategies as well as the timing, frequency, duration, positioning and location of use. 
Several patients compared the fan to breathing exercises. Some patients reported using 
these strategies in a complementary way, while, for others, they seemed interchangeable. 
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“I did try a couple of times without the fan and, with just [breathing] exercises, and it 
were, you know, concentrating on the breathing, and although it was effective, I 
would say it still wasn’t as effective” (FAB 14) 
[In response to being asked what the most useful strategy he had learnt was] “I use 
the fan whether I’m breathless or not, do you know what I mean, as a breathing 
exercise more than anything, so … I’d probably say the fan and the breathing out, 
maybe combined together” (BIS 106) 
“The fan - its physical, err, but significantly one holds the fan in one’s hand, so there 
is a combination of the two which I think I find that quite interesting” (CHAFF 12) 
A small number of patients reported reducing their use of oxygen or as-needed beta agonist 
metered dose inhalers due to replacement with the fan. 
“We didn’t actually know that holding a fan close to your face is as good as oxygen, 
and when he gets gasping for breath you use that don’t you” (BIS 563 carer) 
 “The fan is a help. Where I used to grab my little blue Ventolin puffer, and by the end 
of the day you’d be shaking from that … too much… sometimes I don’t touch it in a 
day.  I take this with me” [Interviewer: “And how many times … would you have used 
the puffer before?” 10, 15 … sometimes 20” (BIS 010) 
For others, the fan was either a supplement to medication or the first step in an escalating 
strategy where medication or oxygen was reserved for breathlessness that did not respond.  
 “When I’m just a little bit out of breath or first thing in the morning … when I’m 
coughing and spluttering I start getting short of breath, I can lay in bed and use that, 
so I don’t have oxygen upstairs.  But when I get really out of breath I have to use the 
oxygen, that [fan] don’t help.  But in the short term, this [fan] is OK” (BIS 126) 
One patient explicitly referred to a preference for using the fan versus medications to avoid 
side-effects, while another highlighted the superior portability of the fan over oxygen. 
“I’ve got me fan ready for when I need it, and me, me inhaler, but I don’t like to use 
the inhaler unless I really need to, because if you read the side effects as well, there’s 
a lot of side effects that come with these inhaler” (CHAFF 19) 
“There’s places, like to my sister’s place where I can’t use the portable oxygen 
because she’s got masses of steps, so the fan would help with the steps” (FAB 4) 
While some people reserved the fan for occasional use, others used it up to four times per 
day. Duration of fan use varied between one and 10 minutes, with most people reporting 
four or five minutes as optimal. While some patients reported directing the fan at their 
mouth and/or nose, others were less specific, and two specifically excluded this part of the 
face. 
“It’s too much [if directed at my mouth], so it has to be off to the side [towards the 
chin and neck]” (CHAFF 14) 
“I find that, if I put it to the side of me face and let it blow up the side of me face, that 
it calms me down a bit” (FAB 27) 
While most patients used the fan to recover from breathlessness, two FAB Study 
participants reported using it as a preventative prior to physical activity. 
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“I don’t wait to become breathless, because if I know I’m going to do a physical 
activity, like in my house, I’m in a multilevel house, I will use the fan before I am 
going to climb stairs” (FAB 40) 
“I’ve tried to remember to use it before I’m doing anything that makes me breathless, 
but I certainly have been using it when I get breathless” (FAB 49) 
Similarly, the location of fan use varied between patients who carried it with them wherever 
they went, used it only at home, or reserved its use for one location within the house. 
Location of use was usually determined by where the fan was most likely to be needed. But 
a small number of patients reported not using the fan outside of the house because they felt 
it attracted unwanted attention, especially during cooler weather when fan use was 
unusual. 
“I take my fan with me where ever I go” (BIS 010) 
 “I’ve put it in my bedside cabinet so that if I wake up during the night for some 
reason and feel compromised it’s handy” (BIS 073) 
“Rather like an injection, you do it privately, if you must. You see, it’s the sort of thing 
… you have with you in the summer, not on a bitterly cold day” (BIS 042) 
A few people were also dissuaded from using the fan in winter because they found airflow 
unpleasantly cold. Other reasons reported for not using the fan reported by one or two 
patients included a need to keep both hands free for daily activities and a concern about 
breathing in dust if the fan was not kept clean. 
“I couldn’t get on with the fan, it’s too cold!” (BIS 598) 
 [In response to being asked what the worst thing about the fan is] “The worst thing I 
would feel is that I had to use my hands” (FAB 4) 
“I think if you’re breathing it in and you’ve got dust on here, I thought ‘well it 
wouldn’t help the pneumonia’” (BIS 098) 
Finally, patients highlighted a number of technical issues, including the need to optimise 
ease of battery change, operability, robustness, safety, noise and flow rate. Preferences for 
the latter varied between patients, with some preferring higher flow rate and others lower. 
[In response to a recommendation to replace the batteries because the fan had 
stopped working] “I couldn’t open it” (BIS 605) 
“It [the fan] was plastic, but it dropped and it broke” (BIS 534) 
“Have to mind the blades so you don’t cut yourself” (BIS 658) 
“If I was at the movies I don’t think I could use it … or you know some places where 
people could hear it, I think it would disturb people” (FAB 3) 
“I find it quite powerful, and I sort of have to hold it away quite a bit” (BIS 523) 
“I think it [fan] does help. Because the other one didn’t help, but this one is, is more... 
is more stronger (FAB 33) 
Many patients praised the portability and ready availability of the hand-held fan. 
“The fan, you know, you can take it anywhere with you. But I always do because I 
keep it in my shopping bag, and where I go, my shopping bag goes” (BIS 140) 
However, two patients also reported using a standard or table top fan at home. 
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“I have a big fan upstairs in the bedroom that goes on when I’m up there” (BIS 140) 
Discussion 
This analysis offers the most detailed exploration to date of perceptions regarding the 
benefits and use of a hand-held fan for chronic breathlessness. Our findings support 
previous calls to offer a fan to patients routinely alongside other non-pharmacological and 
pharmacological management strategies on the grounds it is likely to confer benefits, has 
minimal adverse effects, is low cost and highly portable [8, 9, 13, 16-18, 26, 27]. 
The complex insights regarding the nature of perceived benefits and ways in which the fan 
offered by this analysis supports the importance of including qualitative sub-studies in RCTs 
[28]. Participants described fan-related benefits in terms of a quicker recovery from 
breathlessness rather than as a reduction in breathlessness severity, which has been the 
focus of recent trials [15-18]. With notable exceptions, patients used the fan when resting 
after physical activity rather than prior to or during activity. None reported that it increased 
their capacity for exercise, despite evidence for this on objective measures in two previous 
trials of a standard fan [29] and cool room temperature [30]. While a minority of patients 
reported that using the fan enabled them to increase their activities of daily living, they 
accounted for this in terms of an increased sense of control and confidence rather than 
reduced breathlessness or increased respiratory capacity. 
Airflow and cooling from the fan have been postulated to influence afferent sources for 
respiratory sensation by stimulating upper airway “flow” receptors or trigeminal skin 
receptors [5, 13, 31, 32]. The first of these mechanisms would require cooling of nasal or 
airway mucosa, whereas the second could be achieved by cooling the facial skin. These 
alternative mechanisms are consistent with patients variously deriving benefit from 
directing the fan either at their mouth or other parts of their face. Other, less expected 
mechanisms for benefit postulated by participants included distraction and relaxation, 
which are commonly recommended as self-management strategies in their own right (e.g. 
[12]). Recent preliminary neuroimaging data indicate that facial airflow may modify sensory 
attention involved in the central perception of breathlessness [14].  
Our analysis extends previous results from the FAB Study [18] that some patients may use 
the fan as a first line intervention, reducing their reliance on inhaled beta-agonist 
medications in some instances. The current analysis replicated this finding in this larger 
dataset and found that some patients also used the fan on occasion to replace home 
oxygen. The fan’s potential for replacing both of these ostensibly different treatments raises 
questions about mechanisms not only for the fan but also for medications which involve 
airflow and/or other stimulation of upper airways such as inhaled medication and oxygen. 
Our findings are consistent with trials of oxygen versus medical air for people with chronic 
breathlessness but who do not qualify for long-term oxygen therapy [33, 34]. The fan’s 
potential to replace oxygen for these patients should be explored further with the aim of 
cost containment and reducing risk from oxygen’s flammability. 
Most BIS patients reported the fan to be the most useful strategy they had learned from the 
comprehensive breathlessness service. This finding is consistent with a previous mixed 
methods study in which people with COPD reported ‘getting fresh air’ to be among the most 
effective management strategies [22].  Unlike that study, however, our analysis did not find 
that women were more likely than men to report benefit. A bivariate relationship between 
patient age and perceived benefit was reduced in multivariate analysis, suggesting it was 
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partly accounted for by younger people being more likely to have a malignant diagnosis. But 
neither quantitative nor qualitative analysis identified convincing evidence for a difference 
in fan benefit or use between patients with different diagnoses.   
Finally, our analysis gives useful direction for optimizing fan specifications. Models should be 
highly portable, quiet, robust, and allow easy battery change. A choice of fans within an 
optimal range should be offered that allow tailoring to preference regarding flow rate.  
Limitations 
Findings from this study are limited by the secondary nature of the analysis as well as 
varying sampling and methods in the original studies. While interviews in two of the trials 
focused exclusively on the fan, those in the third and largest study were concerned with 
evaluating a comprehensive breathlessness service of which the fan was just one 
component. Combining data from the two smaller trials with those of the BIS Study 
diversified the settings and practitioners and increased the sample size by a small number 
for analysis of perceived benefit, but between-trial variation in interview questions meant 
sample sizes were reduced for more nuanced topics. Almost all BIS trial participants 
provided qualitative data except where factors outside patients’ control intervened (e.g. 
patient fatigue), and CHAFF and FAB participants were purposively sampled. Thus, 
interviewees were representative of the study samples more generally. 
Also, while the trials gave the same instructions to participants on how to use the fan, they 
differed in the way the fan was presented and frequency, duration and nature of follow-up 
support. The fan was recommended to patients as beneficial to participants as part of the 
BIS Study intervention but, in the CHAFF and FAB studies, benefit was discussed within the 
context of trial equipoise. While expectations of benefit are likely to have contributed to 
effect for some patients, a considerable number from all three studies reported initial 
scepticism about the fan and subsequent surprise at its usefulness in managing 
breathlessness. 
Another limitation is that favourable reports regarding the fan may have partly reflected 
social desirability bias. While the BIS Study employed independent researchers to conduct 
interviews, the smaller numbers of interviews in the CHAFF and FAB studies were conducted 
by the clinical team delivering the intervention. Also, while carer reports did not differ 
substantially from those of patients, it is possible that some carers who were interviewed 
together with patients were inhibited from expressing disagreement. Interviewers in all 
three trials encouraged patients to be frank about their experiences, and participants were 
often less positive about strategies other than the fan. Carers who were interviewed 
separately from patients gave concurrent accounts of benefit. 
Conclusions 
This analysis provides additional evidence to support the routine use of hand-held fans to 
patients with chronic breathlessness, alongside other strategies on the basis that they are 
likely to confer benefits through one or more mechanism(s), are unlikely to do harm, are 
low in cost and are highly portable. It is the first to suggest that a fan may reduce the need 
to use short burst oxygen therapy as well as inhaled beta-agonist medications in some 
patients. Future research should focus on how to optimize instructions on using the fan in 
combination with other strategies, tailoring to individual needs as required. 
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Table 1. Characteristics of three randomised controlled trials providing interview data for secondary analysis of patient perceptions 
regarding a hand-held fan for breathlessness 
Characteristic 
Trial 
BIS CHAFF FAB 
Trial registration number NCT00678405 
 
ISRCTN40230190 ACTRN12614000525684 
Study period (year-year) 2008-2012 2012-2014 2013-2014 
Inclusion criteria Diagnosed appropriately-treated cause of 
breathlessness, troubled by breathlessness in spite 
of optimisation of underlying illness, and might 
benefit from a self-management program 
Adults with intractable 
breathlessness from all causes 
level  3 or higher on the 
modified Medical Research 
Council Dyspnoea scale [33] 
Adults with intractable 
breathlessness from all 
causes level  3 or higher on 
the modified Medical 
Research Council Dyspnoea 
scale [33] 
Total number of patients 
randomized 
154 patients and 98 carers 40 patients and 14 carers 53 patients and 10 carers 
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Interventions First stage interventions (selection and 
application as clinically indicated): hand-held 
fan; explanation and reassurance; breathing 
control; activity pacing and exercise; anxiety 
management; psychological support; 
information fact sheets; emergency plan; 
positioning to reduce work of breathing (rest, 
recovery and activity); education to patient, 
carer and health care generalists; lifestyle 
adjustment; individualised exercise plan; 
relaxation and visualisation; airway clearance 
techniques; advice regarding nutrition and 
hydration; support to family and patient to 
utilise education and self support programmes; 
sleep hygiene; brief cognitive therapy; 
pharmacological review; well-being 
intervention; formal relaxation therapy; 
mindfulness CD; referral to specialist services. 
Second stage interventions: Pharmacological 
review, for example, low dose opioids, 
antidepressants, anxiolytics; referral to 
specialist services (see below); referral for 
LTOT or SBOT assessment; acupuncture. 
Hand-held fan versus Calming 
Hand - a 5-step relaxation 
strategy involving a breathing 
technique and hand 
stretching 
Hand-held fan at either low or 
high flow rates 
Usual care Specialist outpatient appointments in 
secondary care (for example, oncology) which 
may include specialist nurse input and primary 
care services. 
Verbal and written exercise 
advice 
Verbal and written exercise 
advice 
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Quantitative outcomes Patients: breathlessness, distress due to 
breathlessness, disease-specific health-related 
quality of life, anxiety and depression, social 
functioning and service use 
Carers: assessment of patient’s breathlessness, 
distress due to patient’s breathlessness, quality 
of life, anxiety and depression, social 
functioning, carer burden. 
Patients: breathlessness 
intensity, unpleasantness and 
distress, functional 
impairment due to 
breathlessness, distance 
walked until symptom-limited 
maximal performance, self-
efficacy, recovery time 
Carers: carer burden 
Patients: activity levels over 7 
days, life space, 
breathlessness intensity and 
unpleasantness, self-efficacy, 
health service utilization 
Carers: carer burden, 
Interview topics Experiences of and satisfaction with BIS in 
relation to: amount and type of contact; 
location of care; BIS staff;  type of help 
received; frequency of contacts; information 
giving; outcome; and improving BIS. Not all 
participants were asked about the fan 
specifically.  
Personal experience of 
breathlessness and its impact 
on daily living; previous 
experience with health 
services and treatments for 
managing breathlessness; 
experience and perceptions 
of interventions; perceived 
outcomes, effectiveness and 
preferences regarding  fan 
and calming hand.  
Experience of breathlessness, 
the trial and the way in which 
participants 
used the hand held fan (or 
not) and its impact on 
activities and wellbeing. 
Associated publications [20, 28, 35, 36]  None to date [18] 
BIS = Breathlessness Intervention Service Study; CHAFF = Calming Hand and Fan Feasibility Study; FAB = Fan, Activity, Breathlessness Study; 
LTOT = long term oxygen therapy; SBOT = short burst oxygen therapy
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